Pharmacokinetic calculation in missing samples [Study As­sess­ment]

posted by drplacebo – 2008-11-10 10:05 (5643 d 04:04 ago) – Posting: # 2645
Views: 4,136

Dear all
In a two way, single-dose bioequivalence study,we have two subjects missing 3-4 samples in the elimination phase for only one period. Hence in this case when we calculate AUCt, there is going to be an under estimation for AUC of product taken during the missed samples period. I would like to know how to proceed further? should we trucate to equal time points in both periods or drop the complete data of two subjects from the analysis?
Kindly let me know if any regulatory agency has defined the same


Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,990 posts in 4,826 threads, 1,647 registered users;
59 visitors (1 registered, 58 guests [including 5 identified bots]).
Forum time: 15:10 CEST (Europe/Vienna)

If you don’t like something change it;
if you can’t change it, change the way you think about it.    Mary Engelbreit

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5